Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
New findings published in RSNA's Radiology highlight the shortcomings of using nodule characteristics and patient history alone to predict an individual’s true cancer risk.
It is estimated that less than 20% of eligible patients in the U.S. adhere to LCS recommendations, despite numerous studies highlighting the exam’s effectiveness.
Chest X-rays could be the key to mitigating the issue of overdiagnosis in certain patient populations undergoing lung cancer screening, according to new research.
The Mount Sinai Robert F. Smith Mobile Prostate Cancer Screening Unit was developed with the intention of increasing access to screening and supporting prostate health in the Black community.
Those who received customized messages pertaining to their risk of developing colorectal cancer are 34% more likely to complete the screening than those who are offered standard referrals, research shows.
Non-white individuals and people living in less educated, lower income areas are more likely to receive an advanced lung cancer diagnosis, such as stage 4 disease.
Digital breast tomosynthesis exams produce fewer false positive results than standard two-dimensional mammography, though not substantially, experts shared recently in JAMA Open Network.
Extracolonic findings observed on computed tomography colonography scans of cancer patients might identify undetected malignancies more often than previously thought, according to a new study in Clinical Imaging.